 | • レポートコード：MRC2303G135 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の市場調査書によると、世界の癒着防止剤市場規模が、予測期間中、CAGR 7.9％で増加すると推測されています。本書では、癒着防止剤の世界市場について広く調査・分析を行い、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（合成、天然）分析、剤形別（フィルム、液体、ジェル）分析、用途別（一般/腹部外科手術、婦人科系外科手術、心臓血管系外科手術、脳神経外科手術、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などの項目について記載しています。並びに、本書に記載されている企業情報には、Anika Therapeutics、Baxter International、Leader Biomedical、Betatech Medical、FzioMed、BIOSCOMPASS, INC.などが含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の癒着防止剤市場規模：製品別 - 合成癒着防止剤の市場規模 - 天然癒着防止剤の市場規模 ・世界の癒着防止剤市場規模：剤形別 - フィルム型癒着防止剤の市場規模 - 液体型癒着防止剤の市場規模 - ジェル型癒着防止剤の市場規模 ・世界の癒着防止剤市場規模：用途別 - 一般/腹部外科手術における市場規模 - 婦人科系外科手術における市場規模 - 心臓血管系外科手術における市場規模 - 脳神経外科手術における市場規模 - その他用途における市場規模 ・世界の癒着防止剤市場規模：地域別 - 北米の癒着防止剤市場規模 アメリカの癒着防止剤市場規模 カナダの癒着防止剤市場規模 メキシコの癒着防止剤市場規模 … - ヨーロッパの癒着防止剤市場規模 ドイツの癒着防止剤市場規模 イギリスの癒着防止剤市場規模 フランスの癒着防止剤市場規模 … - アジア太平洋の癒着防止剤市場規模 中国の癒着防止剤市場規模 日本の癒着防止剤市場規模 インドの癒着防止剤市場規模 … - 南米/中東の癒着防止剤市場規模 ブラジルの癒着防止剤市場規模 アルゼンチンの癒着防止剤市場規模 サウジアラビアの癒着防止剤市場規模 ・競争状況 ・市場機会・将来動向 |
The adhesion barrier market is expected to register a CAGR of 7.9% over the forecast period.
The pandemic had a significant impact on various surgical procedures initially, as there were strict guidelines specific to each specialty that was implemented and followed by surgeons to continue to provide safe and effective care to their patients during the COVID-19 pandemic. For instance, according to an article published by BMJ Journal in June 2021, surgical programs suspended various non-urgent or elective surgical procedures worldwide during the pandemic. These changes considerably impacted patients, providers, and healthcare organizations. Thus, reducing surgical procedures during the COVID-19 pandemic negatively impacted the market’s growth in 2020. However, the postponed surgeries resumed during the post-pandemic period, which boosted the market’s growth. As the pandemic has subsided, the studied market is expected to grow significantly over the forecast period. Specific factors driving the market growth include increased surgeries and sports-related injuries and rising awareness about the medical implications of adhesions.
According to the data published by British Heart Foundation in December 2021, an estimated 32,938 completed heart operations and other heart procedures were performed in England in October 2021. As adhesion barriers are used after surgeries, increasing operations and surgeries are expected to require adhesion barriers to reduce scars. Therefore, the market is expected to surge over the forecast period.
Moreover, a growing number of surgical procedures due to sports injuries, accidents, and orthopedic surgeries are primary factors driving the adhesion barrier market. There is a high prevalence of orthopedic diseases and other chronic conditions where surgery is suggested as mandatory. According to the data published by the National Safety Council (NSC) for the United States in 2021, bicycling accounted for about 375,797 injuries, and exercise accounted for about 409,224 injuries. The injuries due to an all-terrain vehicle (ATV), moped, and minibike were 238,404, and those due to skateboard, scooter, and hoverboard were 245,177. Therefore, an increasing number of injuries is expected to propel the growth of the adhesion barrier market globally.
Healthcare in developing countries is undergoing rapid changes. The growing population in these countries will likely lead to increased demand for medical devices. The growing burden of diseases and innovative medical treatments contributed to nearly two-thirds of the rise in spending. Spending on healthcare in developing countries is expected to increase during the forecast period. According to the data published by the Office for National Statistics of the United Kingdom in May 2022, the estimated total healthcare expenditure in 2021 was GBP 277 billion (USD 373.4 billion), which increased by 7.4% when compared to the spending in the last year. Specific investments in the healthcare sector offer attractive long-term financial benefits. Medical care is one area where individuals tend to increase spending as incomes grow. Hence, with the increasing healthcare expenditure, the adoption of advanced products, such as adhesion barriers for surgeries, is expected to increase. Thus the studied market is expected to experience growth during the forecast period of the study.
Therefore, due to the aforementioned factors, such as the increased volume of surgeries and sports-related injuries, increasing healthcare expenditure, and rising awareness about the medical implications of adhesions, the studied market is expected to experience growth. However, the high cost of surgical procedures coupled with side effects associated with adhesion barriers and stringent regulations resulting in limited technological innovations are expected to restrain the growth of the adhesion barrier market.
Adhesion Barrier Market Trends
Gynecological Surgeries Segment Expected to Witness Growth
The adhesive disease represents a significant cause of morbidity for postoperative patients. Adhesion barriers have been proven to reduce adhesion-related complications in gynecological surgery. The use of adhesion barriers in open surgery is cost-effective in preventing adhesion-related problems.
According to the WHO updates from June 2021, cesarean section procedures are continuously rising globally, accounting for more than 1 in 5 (21%) childbirths. Moreover, several countries are also experiencing a rise in surgical procedures owing to the rising burden of non-communicable diseases and injuries. Furthermore, per the data published by CDC in July 2022, the cesarean delivery rate increased to 32.1% in the United States in 2021. Cesarean delivery is an abdominal surgery that requires the use of adhesion barriers.
Furthermore, according to an article published by the Journal of Obstetrics and Gynaecology in August 2021, adhesion formation after gynaecologic surgeries is widespread and highly problematic as it directly induces complications and makes subsequent surgeries more difficult. Adhesion barriers to overcoming this problem have proven safe and effective. Adhesion barriers help in significantly reducing both adhesion extent and severity in comparison to untreated control.
Thus, the segment is expected to witness significant growth over the forecast period due to the above-mentioned factors, such as increasing gynecological surgeries and increasing advantages of adhesion barriers in gynecological surgeries.
North America Anticipated to Hold a Significant Market Share
The increasing rate of surgery in the region has been well-documented. Market growth in North America is driven by technological advancement, elderly patients expecting higher levels of function, and reimbursement models incentivizing complex fusion surgery. Adhesion barriers are also valuable for oncology surgeries. Furthermore, growing awareness among the population to approach surgical procedures in case of injuries and chronic disease problems is also driving market growth.
The rising number of orthopedic procedures within the North American region will likely positively impact market growth. For instance, according to the data published by the American Academy of Orthopedic Surgeons in November 2022, an estimated 2,550,232 primary and revision hip and knee arthroplasty procedures were performed in the decade in the United States. It showed a cumulative procedural volume growth of 14% compared to the previous year. As adhesion barriers are used for orthopedic procedures, the increasing number of hip and knee arthroplasty procedures is expected to enhance the market growth.
Additionally, according to the data published by National Safety Council (NSC) in 2021, an estimated 11.7 million people were treated in emergency departments of the United States for injuries resulting from consumer products. Most injuries involve everyday products that are often assumed to be safe. Many injuries occur to vulnerable populations such as older adults and young children. According to the Canadian Institute of Health Information data in February 2022, the most common inpatient surgery in Canada in 2021 was a cesarean section (C-section). This is expected to increase the adoption of adhesion barriers. Thus, the increasing number of injuries that require medical attention and a growing number of surgeries is further expected to boost the market in the region over the forecast period.
Thus, all the aforementioned factors, such as the rise in injury cases and the rising number of orthopedic surgeries, are expected to boost the market in the region.
Adhesion Barrier Market Competitor Analysis
The adhesion barrier market is moderately competitive and consists of several major players. Companies such as Anika Therapeutics, Baxter International, Leader Biomedical, Betatech Medical, FzioMed, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and MAST Biosurgery, among others, hold a substantial market share in the adhesion barrier market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions & Market Definition
1.2 Scope Of The Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in the Volume of Surgeries and Sports-related Injuries
4.2.2 Rising Awareness about the Medical Implications of Adhesions
4.3 Market Restraints
4.3.1 High Cost of Surgical Procedures Coupled with Side Effects Associated with Adhesion Barriers
4.3.2 Stringent Regulations Resulting in Limited Technological Innovations
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD Million)
5.1 By Product
5.1.1 Synthetic Adhesion Barriers
5.1.1.1 Hyaluronic Acid
5.1.1.2 Regenerated Cellulose
5.1.1.3 Polyethylene Glycol
5.1.1.4 Other Synthetic Adhesion Barriers
5.1.2 Natural Adhesion Barriers
5.1.2.1 Collagen
5.1.2.2 Fibrin
5.2 By Formulation
5.2.1 Film
5.2.2 Liquid
5.2.3 Gel
5.3 By Application
5.3.1 General/Abdominal Surgeries
5.3.2 Gynecological Surgeries
5.3.3 Cardiovascular Surgeries
5.3.4 Orthopedic Surgeries
5.3.5 Neurological Surgeries
5.3.6 Other Applications
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Anika Therapeutics
6.1.2 Baxter International
6.1.3 Leader Biomedical
6.1.4 Betatech Medical
6.1.5 FzioMed
6.1.6 BIOSCOMPASS, INC.
6.1.7 Integra LifeSciences Holdings Corporation
6.1.8 Johnson & Johnson
6.1.9 GUNZE LIMITED
6.1.10 Wuhan Sitaili Medical Apparatus Development Co.
6.1.11 TAICEND TECHNOLOGY CO., LTD
6.1.12 MAST Biosurgery
7 MARKET OPPORTUNITIES AND FUTURE TRENDS